Agmatine
•Last Updated: March 8 2023
Agmatine is a metabolite of L-Arginine. It shows promise for alleviating neuropathic pain and drug addiction and shows some potential in protecting against strokes and benefitting cognitive health.
Agmatine is most often used for
Last Updated: March 8 2023
Agmatine is derived from L-arginine and is considered a neurotransmitter and neuromodulator. Animal studies suggest it can be potentially used to treat neuropathic pain and drug addiction.[353][354] Agmatine can be found in certain fermented foods, including wine.
Agmatine plays a role in influencing receptors associated with pain perception, but studies show it has weak general analgesic properties.[355] However, in vitro studies have suggested the neurotransmitter does show dose-dependent pain-relieving effects in the context of treating neuropathic pain.[353]
Agmatine’s effectiveness for drug addiction requires further research, but preliminary animal studies show promise in the treatment of alcohol withdrawal. These studies showed a decrease in alcohol withdrawal symptoms such as tremors and anxiety after supplementation.[354][356] Agmatine has also been studied for its potential benefits for treating cocaine addiction, but animal studies have not shown promising results.[357]. Limited human evidence suggests agmatine may show efficacy for treating depression[358] and nerve-related pain.[359][360][359]
Agmatine is an endogenous neuromodulator derived from L-arginine with an affinity for various transmembrane receptors, including alpha-2 adrenergic, imidazoline I1, and NMDA receptors.[361]
Note that Agmatine is also known as:
- Clonidine-displacing substance
- 4-(aminobutyl)guanidine
- Decarboxylated arginine
Agmatine should not be confused with:
- L-Arginine (parent structure)
There are no standard dosages for agmatine because of the lack of human evidence for its effects. However, a single human study used 1,300-2,670mg of agmatine, daily for the treatment of neuropathic pain. The estimated human dose for improving cognition is 1.6-6.4mg/kg of agmatine, taken orally. This is based off of the 10-40mg/kg dosage range for rats, and is equivalent to 109-435mg for a 150lb person. Supplementation should not exceed 6.4mg/kg of bodyweight.
Studies on agmatine use a daily dosing protocol.
Agmatine is not absorbed well when taken with dietary protein, because it uses the same transporters as arginine. Further research is needed to determine if oral agmatine supplementation provides the same benefits as were observed in animal studies.
What works and what doesn't?
Unlock the full potential of Examine
1.^Naila A, Flint S, Fletcher G, Bremer P, Meerdink GControl of biogenic amines in food--existing and emerging approachesJ Food Sci.(2010 Sep)
2.^Molderings GJ, Haenisch BAgmatine (decarboxylated L-arginine): physiological role and therapeutic potentialPharmacol Ther.(2012 Mar)
3.^Holt A, Baker GBMetabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptorsProg Brain Res.(1995)
4.^Galgano F, Caruso M, Condelli N, Favati FFocused review: agmatine in fermented foodsFront Microbiol.(2012)
7.^De Borba BM, Rohrer JSDetermination of biogenic amines in alcoholic beverages by ion chromatography with suppressed conductivity detection and integrated pulsed amperometric detectionJ Chromatogr A.(2007 Jun 29)
8.^The biogenic amine content of beer; the effect of barley, malting and brewing on amine concentration.()
9.^Kvasnicka F, Voldrich MDetermination of biogenic amines by capillary zone electrophoresis with conductometric detectionJ Chromatogr A.(2006 Jan 20)
10.^Okamoto A, Sugi E, Koizumi Y, Yanagida F, Udaka SPolyamine content of ordinary foodstuffs and various fermented foodsBiosci Biotechnol Biochem.(1997 Sep)
12.^Ruiz-Capillas C, Jiménez-Colmenero FBiogenic amines in meat and meat productsCrit Rev Food Sci Nutr.(2004)
13.^Lorenzo JM, Martínez S, Franco I, Carballo JBiogenic amine content during the manufacture of dry-cured lacón, a Spanish traditional meat product: Effect of some additivesMeat Sci.(2007 Oct)
14.^Bover-Cid S, Izquierdo-Pulido M, Carmen Vidal-Carou MChanges in biogenic amine and polyamine contents in slightly fermented sausages manufactured with and without sugarMeat Sci.(2001 Feb)
15.^Consequences of high-pressure processing of vacuum-packaged frankfurters on the formation of polyamines: Effect of chilled storage.()
17.^Ruiz-Capillas C, Moral AFree amino acids and biogenic amines in red and white muscle of tuna stored in controlled atmospheresAmino Acids.(2004 Mar)
18.^Quality changes of anchovy (Stolephorus heterolobus) under refrigerated storage of different practical industrial methods in Thailand.()
21.^Kirschbaum J, Rebscher K, Brückner HLiquid chromatographic determination of biogenic amines in fermented foods after derivatization with 3,5-dinitrobenzoyl chlorideJ Chromatogr A.(2000 Jun 9)
22.^Gründemann D, Hahne C, Berkels R, Schömig EAgmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2)J Pharmacol Exp Ther.(2003 Feb)
24.^Jones TZ, Giurato L, Guccione S, Ramsay RRInteractions of imidazoline ligands with the active site of purified monoamine oxidase AFEBS J.(2007 Mar)
25.^Remko M, Swart M, Bickelhaupt FMTheoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensivesBioorg Med Chem.(2006 Mar 15)
26.^Zhu MY, Iyo A, Piletz JE, Regunathan SExpression of human arginine decarboxylase, the biosynthetic enzyme for agmatineBiochim Biophys Acta.(2004 Jan 22)
27.^Raasch W, Regunathan S, Li G, Reis DJAgmatine is widely and unequally distributed in rat organsAnn N Y Acad Sci.(1995 Jul 12)
28.^Raasch W, Regunathan S, Li G, Reis DJAgmatine, the bacterial amine, is widely distributed in mammalian tissuesLife Sci.(1995)
29.^Iyer RK, Kim HK, Tsoa RW, Grody WW, Cederbaum SDCloning and characterization of human agmatinaseMol Genet Metab.(2002 Mar)
30.^Mistry SK, Burwell TJ, Chambers RM, Rudolph-Owen L, Spaltmann F, Cook WJ, Morris SM JrCloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virusAm J Physiol Gastrointest Liver Physiol.(2002 Feb)
31.^Haenisch B, von Kügelgen I, Bönisch H, Göthert M, Sauerbruch T, Schepke M, Marklein G, Höfling K, Schröder D, Molderings GJRegulatory mechanisms underlying agmatine homeostasis in humansAm J Physiol Gastrointest Liver Physiol.(2008 Nov)
32.^Dallmann K, Junker H, Balabanov S, Zimmermann U, Giebel J, Walther RHuman agmatinase is diminished in the clear cell type of renal cell carcinomaInt J Cancer.(2004 Jan 20)
33.^Bernstein HG, Stich C, Jäger K, Dobrowolny H, Wick M, Steiner J, Veh R, Bogerts B, Laube GAgmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disordersNeuropharmacology.(2012 Jan)
34.^Sastre M, Galea E, Feinstein D, Reis DJ, Regunathan SMetabolism of agmatine in macrophages: modulation by lipopolysaccharide and inhibitory cytokinesBiochem J.(1998 Mar 15)
35.^Haenisch B, Bönisch H, Cichon S, Allam JP, Novak N, Molderings GJEffects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycleLeuk Res.(2011 Sep)
36.^Regunathan S, Youngson C, Raasch W, Wang H, Reis DJImidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferationJ Pharmacol Exp Ther.(1996 Mar)
37.^Gorbatyuk OS, Milner TA, Wang G, Regunathan S, Reis DJLocalization of agmatine in vasopressin and oxytocin neurons of the rat hypothalamic paraventricular and supraoptic nucleiExp Neurol.(2001 Oct)
38.^Reis DJ, Yang XC, Milner TAAgmatine containing axon terminals in rat hippocampus form synapses on pyramidal cellsNeurosci Lett.(1998 Jul 10)
39.^Otake K, Ruggiero DA, Regunathan S, Wang H, Milner TA, Reis DJRegional localization of agmatine in the rat brain: an immunocytochemical studyBrain Res.(1998 Mar 16)
41.^Wang H, Regunathan S, Youngson C, Bramwell S, Reis DJAn antibody to agmatine localizes the amine in bovine adrenal chromaffin cellsNeurosci Lett.(1995 Jan 2)
42.^Molderings GJ, Heinen A, Menzel S, Lübbecke F, Homann J, Göthert MGastrointestinal uptake of agmatine: distribution in tissues and organs and pathophysiologic relevanceAnn N Y Acad Sci.(2003 Dec)
43.^Gilad GM, Wollam Y, Iaina A, Rabey JM, Chernihovsky T, Gilad VHMetabolism of agmatine into urea but not into nitric oxide in rat brainNeuroreport.(1996 Jul 29)
44.^Komori Y, Wallace GC, Fukuto JMInhibition of purified nitric oxide synthase from rat cerebellum and macrophage by L-arginine analogsArch Biochem Biophys.(1994 Dec)
45.^Yokoi I, Kabuto H, Habu H, Inada K, Toma J, Mori AStructure-activity relationships of arginine analogues on nitric oxide synthase activity in the rat brainNeuropharmacology.(1994 Nov)
46.^Sennequier N, Stuehr DJAnalysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthaseBiochemistry.(1996 May 7)
47.^Novotny WF, Chassande O, Baker M, Lazdunski M, Barbry PDiamine oxidase is the amiloride-binding protein and is inhibited by amiloride analoguesJ Biol Chem.(1994 Apr 1)
48.^McGrath AP, Hilmer KM, Collyer CA, Dooley DM, Guss JMA new crystal form of human diamine oxidaseActa Crystallogr Sect F Struct Biol Cryst Commun.(2010 Feb 1)
49.^Cabella C, Gardini G, Corpillo D, Testore G, Bedino S, Solinas SP, Cravanzola C, Vargiu C, Grillo MA, Colombatto STransport and metabolism of agmatine in rat hepatocyte culturesEur J Biochem.(2001 Feb)
50.^Mella C, Martínez F, de Los Angeles García M, Nualart F, Castro V, Bustos P, Carvajal N, Uribe EExpression and localization of an agmatinase-like protein in the rat brainHistochem Cell Biol.(2010 Aug)
51.^Polo LM, Gil-Ortiz F, Cantín A, Rubio VNew insight into the transcarbamylase family: the structure of putrescine transcarbamylase, a key catalyst for fermentative utilization of agmatinePLoS One.(2012)
52.^Satriano J, Matsufuji S, Murakami Y, Lortie MJ, Schwartz D, Kelly CJ, Hayashi S, Blantz RCAgmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levelsJ Biol Chem.(1998 Jun 19)
53.^Babál P, Ruchko M, Campbell CC, Gilmour SP, Mitchell JL, Olson JW, Gillespie MNRegulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cellsJ Pharmacol Exp Ther.(2001 Feb)
55.^Llácer JL, Polo LM, Tavárez S, Alarcón B, Hilario R, Rubio VThe gene cluster for agmatine catabolism of Enterococcus faecalis: study of recombinant putrescine transcarbamylase and agmatine deiminase and a snapshot of agmatine deiminase catalyzing its reactionJ Bacteriol.(2007 Feb)
56.^Wargnies B, Lauwers N, Stalon VStructure and properties of the putrescine carbamoyltransferase of Streptococcus faecalisEur J Biochem.(1979 Nov 1)
57.^Simon JP, Stalon VEnzymes of agmatine degradation and the control of their synthesis in Streptococcus faecalisJ Bacteriol.(1982 Nov)
59.^Simon JP, Wargnies B, Stalon VControl of enzyme synthesis in the arginine deiminase pathway of Streptococcus faecalisJ Bacteriol.(1982 Jun)
60.^Xi H, Schneider BL, Reitzer LPurine catabolism in Escherichia coli and function of xanthine dehydrogenase in purine salvageJ Bacteriol.(2000 Oct)
61.^TIGIER H, GRISOLIA SINDUCTION OF CARBAMYL-P SPECIFIC OXAMATE TRANSCARBAMYLASE BY PARABANIC ACID IN A STREPTOCOCCUSBiochem Biophys Res Commun.(1965 Apr 9)
62.^Aricioglu F, Regunathan S, Piletz JEIs agmatine an endogenous factor against stressAnn N Y Acad Sci.(2003 Dec)
63.^Piletz JE, May PJ, Wang G, Zhu HAgmatine crosses the blood-brain barrierAnn N Y Acad Sci.(2003 Dec)
64.^Feng Y, Halaris AE, Piletz JEDetermination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detectionJ Chromatogr B Biomed Sci Appl.(1997 Apr 11)
65.^Regunathan S, Dozier D, Takkalapalli R, Phillips WJAgmatine levels in the cerebrospinal fluid of normal human volunteersJ Pain Palliat Care Pharmacother.(2009)
66.^Jo I, Han C, Ahn Jo S, Seo JA, Park MH, Kim NHLow levels of plasma agmatine in the metabolic syndromeMetab Syndr Relat Disord.(2010 Feb)
67.^Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJAgmatine: an endogenous clonidine-displacing substance in the brainScience.(1994 Feb 18)
68.^Uzbay T, Goktalay G, Kayir H, Eker SS, Sarandol A, Oral S, Buyukuysal L, Ulusoy G, Kirli SIncreased plasma agmatine levels in patients with schizophreniaJ Psychiatr Res.(2013 May 7)
69.^Halaris A, Zhu H, Feng Y, Piletz JEPlasma agmatine and platelet imidazoline receptors in depressionAnn N Y Acad Sci.(1999 Jun 21)
70.^Molderings GJ, Heinen A, Menzel S, Göthert MExposure of rat isolated stomach and rats in vivo to {(14)C}agmatine: accumulation in the stomach wall and distribution in various tissuesFundam Clin Pharmacol.(2002 Jun)
71.^Li YF, Gong ZH, Cao JB, Wang HL, Luo ZP, Li JAntidepressant-like effect of agmatine and its possible mechanismEur J Pharmacol.(2003 May 23)
72.^Roberts JC, Grocholski BM, Kitto KF, Fairbanks CAPharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouseJ Pharmacol Exp Ther.(2005 Sep)
73.^Raasch W, Schäfer U, Qadri F, Dominiak PAgmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reactionBr J Pharmacol.(2002 Feb)
74.^Satriano J, Isome M, Casero RA Jr, Thomson SC, Blantz RCPolyamine transport system mediates agmatine transport in mammalian cellsAm J Physiol Cell Physiol.(2001 Jul)
75.^Agmatine Is Efficiently Transported by Non-Neuronal Monoamine Transporters Extraneuronal Monoamine Transporter (EMT) and Organic Cation Transporter 2 (OCT2).()
77.^Endogenous pain modulation: Neuropharmacokinetic/dynamic studies of the endogenous NMDA receptor antagonist/NOS inhibitor, agmatine.()
79.^Sastre M, Regunathan S, Galea E, Reis DJAgmatinase activity in rat brain: a metabolic pathway for the degradation of agmatineJ Neurochem.(1996 Oct)
80.^Goracke-Postle CJ, Nguyen HO, Stone LS, Fairbanks CARelease of tritiated agmatine from spinal synaptosomesNeuroreport.(2006 Jan 23)
81.^Sastre M, Regunathan S, Reis DJUptake of agmatine into rat brain synaptosomes: possible role of cation channelsJ Neurochem.(1997 Dec)
82.^Goracke-Postle CJ, Overland AC, Riedl MS, Stone LS, Fairbanks CAPotassium- and capsaicin-induced release of agmatine from spinal nerve terminalsJ Neurochem.(2007 Sep)
83.^Goracke-Postle CJ, Overland AC, Stone LS, Fairbanks CAAgmatine transport into spinal nerve terminals is modulated by polyamine analogsJ Neurochem.(2007 Jan)
84.^Regunathan S, Feinstein DL, Raasch W, Reis DJAgmatine (decarboxylated arginine) is synthesized and stored in astrocytesNeuroreport.(1995 Oct 2)
85.^Zomkowski AD, Santos AR, Rodrigues ALPutrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in miceProg Neuropsychopharmacol Biol Psychiatry.(2006 Dec 30)
86.^Molderings GJ, Menzel S, Kathmann M, Schlicker E, Göthert MDual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activationBr J Pharmacol.(2000 Aug)
87.^Dias Elpo Zomkowski A, Oscar Rosa A, Lin J, Santos AR, Calixto JB, Lúcia Severo Rodrigues AEvidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming testBrain Res.(2004 Oct 15)
88.^Gibson DA, Harris BR, Rogers DT, Littleton JMRadioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodilBrain Res.(2002 Oct 11)
89.^Lewin AH, Sun G, Fudala L, Navarro H, Zhou LM, Popik P, Faynsteyn A, Skolnick PMolecular features associated with polyamine modulation of NMDA receptorsJ Med Chem.(1998 Mar 12)
90.^Jiang XZ, Li YF, Zhang YZ, Chen HX, Li J, Wang NP5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatineYao Xue Xue Bao.(2008 May)
91.^Piletz JE, Chikkala DN, Ernsberger PComparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptorsJ Pharmacol Exp Ther.(1995 Feb)
92.^Morrissey JJ, Klahr SAgmatine activation of nitric oxide synthase in endothelial cellsProc Assoc Am Physicians.(1997 Jan)
93.^Chang CH, Wu HT, Cheng KC, Lin HJ, Cheng JTIncrease of beta-endorphin secretion by agmatine is induced by activation of imidazoline I(2A) receptors in adrenal gland of ratsNeurosci Lett.(2010 Jan 14)
94.^Pinthong D, Hussain JF, Kendall DA, Wilson VGComparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sitesBr J Pharmacol.(1995 Jun)
95.^Pinthong D, Wright IK, Hanmer C, Millns P, Mason R, Kendall DA, Wilson VGAgmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptorsNaunyn Schmiedebergs Arch Pharmacol.(1995 Jan)
96.^Pinthong D, Kendall DA, Maclennan SJ, Eglen RM, Wilson VGNo evidence for activation of alpha(2)-adrenoceptors by methanolic extracts of bovine brain and lung containing clonidine-displacing substanceAnn N Y Acad Sci.(2003 Dec)
97.^Taksande BG, Kotagale NR, Nakhate KT, Mali PD, Kokare DM, Hirani K, Subhedar NK, Chopde CT, Ugale RRAgmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide YBr J Pharmacol.(2011 Sep)
98.^Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos AR, Rodrigues ALAgmatine produces antidepressant-like effects in two models of depression in miceNeuroreport.(2002 Mar 25)
99.^Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M, García-Sevilla JAInhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liverBr J Pharmacol.(1997 Jul)
100.^Raasch W, Muhle H, Dominiak PModulation of MAO activity by imidazoline and guanidine derivativesAnn N Y Acad Sci.(1999 Jun 21)
101.^Regunathan S, Meeley MP, Reis DJExpression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medullaBiochem Pharmacol.(1993 Apr 22)
102.^Head GA, Mayorov DNImidazoline receptors, novel agents and therapeutic potentialCardiovasc Hematol Agents Med Chem.(2006 Jan)
103.^González C, Regunathan S, Reis DJ, Estrada CAgmatine, an endogenous modulator of noradrenergic neurotransmission in the rat tail arteryBr J Pharmacol.(1996 Oct)
104.^Molderings GJ, Göthert MInhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sitesNaunyn Schmiedebergs Arch Pharmacol.(1995 May)
105.^Askalany AR, Yamakura T, Petrenko AB, Kohno T, Sakimura K, Baba HEffect of agmatine on heteromeric N-methyl-D-aspartate receptor channelsNeurosci Res.(2005 Aug)
106.^Yang XC, Reis DJAgmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neuronsJ Pharmacol Exp Ther.(1999 Feb)
107.^Reynolds IJArcaine uncovers dual interactions of polyamines with the N-methyl-D-aspartate receptorJ Pharmacol Exp Ther.(1990 Dec)
108.^Anis N, Sherby S, Goodnow R Jr, Niwa M, Konno K, Kallimopoulos T, Bukownik R, Nakanishi K, Usherwood P, Eldefrawi A, et alStructure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptorsJ Pharmacol Exp Ther.(1990 Sep)
109.^Zhu MY, Piletz JE, Halaris A, Regunathan SEffect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cellsCell Mol Neurobiol.(2003 Oct)
111.^Burban A, Faucard R, Armand V, Bayard C, Vorobjev V, Arrang JMHistamine potentiates N-methyl-D-aspartate receptors by interacting with an allosteric site distinct from the polyamine binding siteJ Pharmacol Exp Ther.(2010 Mar)
112.^Watanabe C, Orito T, Watanabe H, Mizoguchi H, Yonezawa A, Yanai K, Mobarakeh JI, Onodera K, Sakurada T, Sakurada SIntrathecal high-dose histamine induces spinally-mediated nociceptive behavioral responses through a polyamine site of NMDA receptorsEur J Pharmacol.(2008 Feb 26)
113.^Wade CL, Eskridge LL, Nguyen HO, Kitto KF, Stone LS, Wilcox G, Fairbanks CAImmunoneutralization of agmatine sensitizes mice to micro-opioid receptor toleranceJ Pharmacol Exp Ther.(2009 Nov)
114.^Lewis B, Wellmann KA, Barron SAgmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposurePharmacol Biochem Behav.(2007 Nov)
115.^Barron S, Lewis B, Wellmann K, Carter M, Farook J, Ring J, Rogers DT, Holley R, Crooks P, Littleton JPolyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependenceRecent Pat CNS Drug Discov.(2012 Aug)
116.^Rawls SM, Gomez T, Raffa RBAn NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2)Pharmacol Biochem Behav.(2007 Mar)
117.^Demady DR, Jianmongkol S, Vuletich JL, Bender AT, Osawa YAgmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzymeMol Pharmacol.(2001 Jan)
118.^Nishida CR, Ortiz de Montellano PRElectron transfer and catalytic activity of nitric oxide synthases. Chimeric constructs of the neuronal, inducible, and endothelial isoformsJ Biol Chem.(1998 Mar 6)
119.^Abu-Soud HM, Feldman PL, Clark P, Stuehr DJElectron transfer in the nitric-oxide synthases. Characterization of L-arginine analogs that block heme iron reductionJ Biol Chem.(1994 Dec 23)
120.^Alagarsamy S, Johnson KMVoltage-dependent calcium channel involvement in NMDA-induced activation of NOSNeuroreport.(1995 Nov 13)
121.^Fairbanks CA, Wilcox GLAcute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine toleranceJ Pharmacol Exp Ther.(1997 Sep)
122.^Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GWBlockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitorProc Natl Acad Sci U S A.(1993 Jun 1)
123.^Elliott K, Minami N, Kolesnikov YA, Pasternak GW, Inturrisi CEThe NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioidsPain.(1994 Jan)
124.^Elliott K, Kest B, Man A, Kao B, Inturrisi CEN-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug developmentNeuropsychopharmacology.(1995 Dec)
125.^Loring RHAgmatine acts as an antagonist of neuronal nicotinic receptorsBr J Pharmacol.(1990 Jan)
126.^Krass M, Wegener G, Vasar E, Volke VAntidepressant-like effect of agmatine is not mediated by serotoninBehav Brain Res.(2008 Apr 9)
127.^Molderings GJ, Schmidt K, Bönisch H, Göthert MInhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sitesNaunyn Schmiedebergs Arch Pharmacol.(1996 Aug-Sep)
128.^Taksande BG, Kotagale NR, Tripathi SJ, Ugale RR, Chopde CTAntidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatineNeuropharmacology.(2009 Sep)
129.^Kim HS, Park IS, Lim HK, Choi HSNMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in PCPA-treated miceArch Pharm Res.(1999 Apr)
130.^Kim HS, Son YR, Kim SHNitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in miceLife Sci.(1999)
131.^Kotagale NR, Tripathi SJ, Aglawe MM, Chopde CT, Umekar MJ, Taksande BGEvidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim testPharmacol Biochem Behav.(2013 Jun)
132.^Tsou K, Brown S, Sañudo-Peña MC, Mackie K, Walker JMImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous systemNeuroscience.(1998 Mar)
133.^Pettit DA, Harrison MP, Olson JM, Spencer RF, Cabral GAImmunohistochemical localization of the neural cannabinoid receptor in rat brainJ Neurosci Res.(1998 Feb 1)
134.^Ruggiero DA, Regunathan S, Wang H, Milner TA, Reis DJImmunocytochemical localization of an imidazoline receptor protein in the central nervous systemBrain Res.(1998 Jan 12)
135.^Molderings GJ, Likungu J, Göthert MPresynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationshipNaunyn Schmiedebergs Arch Pharmacol.(1999 Aug)
136.^Aggarwal S, Shavalian B, Kim E, Rawls SMAgmatine enhances cannabinoid action in the hot-plate assay of thermal nociceptionPharmacol Biochem Behav.(2009 Oct)
137.^Rawls SM, Tallarida RJ, Zisk JAgmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergyEur J Pharmacol.(2006 Dec 28)
138.^Compton DR, Gold LH, Ward SJ, Balster RL, Martin BRAminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinolJ Pharmacol Exp Ther.(1992 Dec)
139.^Thorat SN, Bhargava HNEffects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in miceBrain Res.(1994 Dec 19)
140.^Spina E, Trovati A, Parolaro D, Giagnoni GA role of nitric oxide in WIN 55,212-2 tolerance in miceEur J Pharmacol.(1998 Feb 19)
141.^Molderings GJ, Likungu J, Jakschik J, Göthert MPresynaptic imidazoline receptors and non-adrenoceptor {3H}-idazoxan binding sites in human cardiovascular tissuesBr J Pharmacol.(1997 Sep)
142.^Wong CS, Cherng CH, Luk HN, Ho ST, Tung CSEffects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptorsEur J Pharmacol.(1996 Feb 15)
143.^Li J, Li X, Pei G, Qin BYEffects of agmatine on tolerance to and substance dependence on morphine in miceZhongguo Yao Li Xue Bao.(1999 Mar)
144.^Kolesnikov Y, Jain S, Pasternak GWModulation of opioid analgesia by agmatineEur J Pharmacol.(1996 Jan 18)
145.^Yeşilyurt O, Uzbay ITAgmatine potentiates the analgesic effect of morphine by an alpha(2)-adrenoceptor-mediated mechanism in miceNeuropsychopharmacology.(2001 Jul)
146.^Bhalla S, Rapolaviciute V, Gulati ADetermination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874Eur J Pharmacol.(2011 Jan 25)
147.^Su RB, Lu XQ, Huang Y, Liu Y, Gong ZH, Wei XL, Wu N, Li JEffects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeysEur J Pharmacol.(2008 Jun 10)
148.^Gold MS, Redmond DE Jr, Kleber HDClonidine blocks acute opiate-withdrawal symptomsLancet.(1978 Sep 16)
149.^Kosten TAClonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawalEur J Pharmacol.(1994 Mar 11)
150.^Maldonado RParticipation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidenceNeurosci Biobehav Rev.(1997 Jan)
151.^Iglesias V, Alguacil LF, Alamo C, Cuenca EEffects of yohimbine on morphine analgesia and physical dependence in the ratEur J Pharmacol.(1992 Jan 28)
152.^Dwoskin LP, Neal BS, Sparber SBYohimbine exacerbates and clonidine attenuates acute morphine withdrawal in ratsEur J Pharmacol.(1983 Jun 3)
153.^Wade CL, Schuster DJ, Domingo KM, Kitto KF, Fairbanks CASupraspinally-administered agmatine attenuates the development of oral fentanyl self-administrationEur J Pharmacol.(2008 Jun 10)
154.^Morgan AD, Campbell UC, Fons RD, Carroll MEEffects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in ratsPharmacol Biochem Behav.(2002 Jul)
155.^Huston JP, Silva MA, Topic B, Müller CPWhat's conditioned in conditioned place preferenceTrends Pharmacol Sci.(2013 Mar)
156.^Tahsili-Fahadan P, Yahyavi-Firouz-Abadi N, Khoshnoodi MA, Motiei-Langroudi R, Tahaei SA, Ghahremani MH, Dehpour ARAgmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha2-adrenoceptorsNeuropsychopharmacology.(2006 Aug)
157.^Yu Y, Chen Z, Li WG, Cao H, Feng EG, Yu F, Liu H, Jiang H, Xu TLA nonproton ligand sensor in the acid-sensing ion channelNeuron.(2010 Oct 6)
158.^Li WG, Yu Y, Zhang ZD, Cao H, Xu TLASIC3 channels integrate agmatine and multiple inflammatory signals through the nonproton ligand sensing domainMol Pain.(2010 Dec 8)
159.^Wemmie JA, Price MP, Welsh MJAcid-sensing ion channels: advances, questions and therapeutic opportunitiesTrends Neurosci.(2006 Oct)
160.^Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski MA proton-gated cation channel involved in acid-sensingNature.(1997 Mar 13)
161.^de Weille JR, Bassilana F, Lazdunski M, Waldmann RIdentification, functional expression and chromosomal localisation of a sustained human proton-gated cation channelFEBS Lett.(1998 Aug 21)
162.^Salinas M, Lazdunski M, Lingueglia EStructural elements for the generation of sustained currents by the acid pain sensor ASIC3J Biol Chem.(2009 Nov 13)
163.^Deval E, Noël J, Lay N, Alloui A, Diochot S, Friend V, Jodar M, Lazdunski M, Lingueglia EASIC3, a sensor of acidic and primary inflammatory painEMBO J.(2008 Nov 19)
165.^Zhang M, Wang H, Tracey KJRegulation of macrophage activation and inflammation by spermine: a new chapter in an old storyCrit Care Med.(2000 Apr)
166.^Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, Nguyen HO, Grocholski BM, Shoeman DW, Kehl LJ, Regunathan S, Reis DJ, Yezierski RP, Wilcox GLAgmatine reverses pain induced by inflammation, neuropathy, and spinal cord injuryProc Natl Acad Sci U S A.(2000 Sep 12)
168.^Keynan O, Mirovsky Y, Dekel S, Gilad VH, Gilad GMSafety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled TrialPain Med.(2010 Mar)
169.^Buchhalter AR, Fant RV, Henningfield JENovel pharmacological approaches for treating tobacco dependence and withdrawal: current statusDrugs.(2008)
170.^Gourlay S, Forbes A, Marriner T, Kutin J, McNeil JA placebo-controlled study of three clonidine doses for smoking cessationClin Pharmacol Ther.(1994 Jan)
171.^Yamanaka K, Oshita M, Muramatsu IAlteration of alpha and muscarinic receptors in rat brain and heart following chronic nicotine treatmentBrain Res.(1985 Dec 2)
172.^Kotagale NR, Taksande BG, Gahane AY, Ugale RR, Chopde CTRepeated agmatine treatment attenuates nicotine sensitization in mice: modulation by alpha2-adrenoceptorsBehav Brain Res.(2010 Dec 1)
173.^Zaniewska M, McCreary AC, Sezer G, Przegaliński E, Filip MEffects of agmatine on nicotine-evoked behavioral responses in ratsPharmacol Rep.(2008 Sep-Oct)
174.^Uzbay IT, Yeşilyurt O, Celik T, Ergün H, Işimer AEffects of agmatine on ethanol withdrawal syndrome in ratsBehav Brain Res.(2000 Jan)
175.^Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CTAgmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in ratsEur J Pharmacol.(2010 Jul 10)
176.^Littleton JM, Lovinger D, Liljequist S, Ticku R, Matsumoto I, Barron SRole of polyamines and NMDA receptors in ethanol dependence and withdrawalAlcohol Clin Exp Res.(2001 May)
177.^Gibson DA, Harris BR, Prendergast MA, Hart SR, Blanchard JA 2nd, Holley RC, Pedigo NW, Littleton JMPolyamines contribute to ethanol withdrawal-induced neurotoxicity in rat hippocampal slice cultures through interactions with the NMDA receptorAlcohol Clin Exp Res.(2003 Jul)
178.^Collins ED, Ward AS, McDowell DM, Foltin RW, Fischman MWThe effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humansBehav Pharmacol.(1998 Nov)
179.^Collins ED, Vosberg SK, Ward AS, Haney M, Foltin RWThe effects of acute pretreatment with high-dose memantine on the cardiovascular and behavioral effects of cocaine in humansExp Clin Psychopharmacol.(2007 Jun)
180.^Rawls SM, Rodriguez T, Baron DA, Raffa RBA nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in PlanariaBrain Res.(2006 Jul 12)
181.^Cantin L, Lenoir M, Augier E, Vanhille N, Dubreucq S, Serre F, Vouillac C, Ahmed SHCocaine is low on the value ladder of rats: possible evidence for resilience to addictionPLoS One.(2010 Jul 28)
182.^Lenoir M, Serre F, Cantin L, Ahmed SHIntense sweetness surpasses cocaine rewardPLoS One.(2007 Aug 1)
183.^Wang CC, Chio CC, Chang CH, Kuo JR, Chang CPBeneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemiaBMC Pharmacol.(2010 Sep 6)
184.^Agmatine reduced the expressions of nitric oxide synthase and peroxynitrite formation in rat cerebral cortex after transient global cerebral ischemia.()
185.^Kim JH, Lee YW, Park KA, Lee WT, Lee JEAgmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemiaJ Cereb Blood Flow Metab.(2010 May)
186.^Lee WT, Hong S, Yoon SH, Kim JH, Park KA, Seong GJ, Lee JENeuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa BBrain Res.(2009 Jul 24)
187.^Kim JH, Yenari MA, Giffard RG, Cho SW, Park KA, Lee JEAgmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injuryExp Neurol.(2004 Sep)
188.^Feng Y, Piletz JE, Leblanc MHAgmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal ratsPediatr Res.(2002 Oct)
189.^Iadecola CBright and dark sides of nitric oxide in ischemic brain injuryTrends Neurosci.(1997 Mar)
190.^Moro MA, Cárdenas A, Hurtado O, Leza JC, Lizasoain IRole of nitric oxide after brain ischaemiaCell Calcium.(2004 Sep-Oct)
191.^Raghavan SA, Dikshit MVascular regulation by the L-arginine metabolites, nitric oxide and agmatinePharmacol Res.(2004 May)
192.^Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MAEffects of cerebral ischemia in mice deficient in neuronal nitric oxide synthaseScience.(1994 Sep 23)
193.^Mun CH, Lee WT, Park KA, Lee JERegulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brainAnat Cell Biol.(2010 Sep)
194.^Ma T, Yang B, Gillespie A, Carlson EJ, Epstein CJ, Verkman ASGeneration and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4J Clin Invest.(1997 Sep 1)
195.^Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, Chan P, Verkman ASAquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic strokeNat Med.(2000 Feb)
196.^Ribeiro Mde C, Hirt L, Bogousslavsky J, Regli L, Badaut JTime course of aquaporin expression after transient focal cerebral ischemia in miceJ Neurosci Res.(2006 May 15)
197.^Gilad GM, Salame K, Rabey JM, Gilad VHAgmatine treatment is neuroprotective in rodent brain injury modelsLife Sci.(1996)
198.^Panet H, Barzilai A, Daily D, Melamed E, Offen DActivation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cellsJ Neurochem.(2001 Apr)
199.^Seo SK, Yang W, Park YM, Lee WT, Park KA, Lee JEOverexpression of human arginine decarboxylase rescues human mesenchymal stem cells against H₂O₂ toxicity through cell survival protein activationJ Korean Med Sci.(2013 Mar)
200.^Santhanam AV, Viswanathan S, Dikshit MActivation of protein kinase B/Akt and endothelial nitric oxide synthase mediates agmatine-induced endothelium-dependent relaxationEur J Pharmacol.(2007 Oct 31)
201.^Li W, Wang H, Kuang CY, Zhu JK, Yu Y, Qin ZX, Liu J, Huang LAn essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitroMol Cell Biochem.(2012 Apr)
202.^Kanwar JR, Kamalapuram SK, Kanwar RKTargeting survivin in cancer: the cell-signalling perspectiveDrug Discov Today.(2011 Jun)
203.^Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E, Bearth E, Peng JR, Gaffney P, Ondrey FGInhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathwaysClin Cancer Res.(2010 Jan 1)
204.^Young ND, Galston AWPutrescine and Acid Stress : Induction of Arginine Decarboxylase Activity and Putrescine Accumulation by Low pHPlant Physiol.(1983 Apr)
205.^Bliven KA, Fisher DJ, Maurelli ATCharacterization of the activity and expression of arginine decarboxylase in human and animal Chlamydia pathogensFEMS Microbiol Lett.(2012 Dec)
206.^Pothipongsa A, Jantaro S, Incharoensakdi APolyamines induced by osmotic stress protect Synechocystis sp. PCC 6803 cells and arginine decarboxylase transcripts against UV-B radiationAppl Biochem Biotechnol.(2012 Nov)
207.^Xu X, Shi G, Jia RChanges of polyamine levels in roots of Sagittaria sagittifolia L. under copper stressEnviron Sci Pollut Res Int.(2011 Aug)
208.^Ruiz-Durántez E, Ruiz-Ortega JA, Pineda J, Ugedo LEffect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxideBr J Pharmacol.(2002 Mar)
209.^Weiss JM, Stout JC, Aaron MF, Quan N, Owens MJ, Butler PD, Nemeroff CBDepression and anxiety: role of the locus coeruleus and corticotropin-releasing factorBrain Res Bull.(1994)
210.^Lavinsky D, Arteni NS, Netto CAAgmatine induces anxiolysis in the elevated plus maze task in adult ratsBehav Brain Res.(2003 Apr 17)
211.^Aricioglu F, Altunbas HIs agmatine an endogenous anxiolytic/antidepressant agentAnn N Y Acad Sci.(2003 Dec)
212.^Gong ZH, Li YF, Zhao N, Yang HJ, Su RB, Luo ZP, Li JAnxiolytic effect of agmatine in rats and miceEur J Pharmacol.(2006 Nov 21)
213.^Halaris A, Piletz JERelevance of imidazoline receptors and agmatine to psychiatry: a decade of progressAnn N Y Acad Sci.(2003 Dec)
214.^Kaster MP, Ferreira PK, Santos AR, Rodrigues ALEffects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathwayBehav Brain Res.(2005 Dec 7)
215.^Zomkowski AD, Santos AR, Rodrigues ALEvidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming testNeurosci Lett.(2005 Jun 24)
216.^Budni J, Gadotti VM, Kaster MP, Santos AR, Rodrigues ALRole of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming testEur J Pharmacol.(2007 Dec 1)
220.^Kobayashi T, Washiyama K, Ikeda KInhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugsNeuropsychopharmacology.(2004 Oct)
221.^Kaster MP, Budni J, Binfaré RW, Santos AR, Rodrigues ALThe inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming testProg Neuropsychopharmacol Biol Psychiatry.(2007 Apr 13)
222.^Budni J, Freitas AE, Binfaré RW, Rodrigues ALRole of potassium channels in the antidepressant-like effect of folic acid in the forced swimming test in micePharmacol Biochem Behav.(2012 Mar)
223.^Redrobe JP, Pinot P, Bourin MThe effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in miceFundam Clin Pharmacol.(1996)
224.^Bortolatto CF, Jesse CR, Wilhelm EA, Nogueira CWInvolvement of potassium channels in the antidepressant-like effect of venlafaxine in miceLife Sci.(2010 Feb 27)
225.^Kelly JS, Larkman P, Penington NJ, Rainnie DG, McAllister-Williams H, Hodgkiss JSerotonin receptor heterogeneity and the role of potassium channels in neuronal excitabilityAdv Exp Med Biol.(1991)
226.^Weng XC, Gai XD, Zheng JQ, Li JAgmatine blocked voltage-gated calcium channel in cultured rat hippocampal neuronsActa Pharmacol Sin.(2003 Aug)
227.^The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study.()
228.^Pedrazzini T, Pralong F, Grouzmann ENeuropeptide Y: the universal soldierCell Mol Life Sci.(2003 Feb)
229.^Kask A, Rägo L, Harro JEvidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226Br J Pharmacol.(1998 Aug)
230.^Huguet F, Comoy E, Piriou A, Bohuon CAge-related changes of noradrenergic-NPY interaction in rat brain: norepinephrine, NPY levels and alpha-adrenoceptorsBrain Res.(1993 Oct 22)
231.^Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JMColocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamusJ Comp Neurol.(1985 Nov 8)
232.^Everitt BJ, Hökfelt T, Terenius L, Tatemoto K, Mutt V, Goldstein MDifferential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the ratNeuroscience.(1984 Feb)
233.^Franco-Cereceda A, Nagata M, Svensson TH, Lundberg JMDifferential effects of clonidine and reserpine treatment on neuropeptide Y content in some sympathetically innervated tissues of the guinea-pigEur J Pharmacol.(1987 Oct 13)
234.^Smiałowska M, Obuchowicz E, Turchan J, Herman ZS, Przewłocki RClonidine administration increases neuropeptide Y immunoreactivity and neuropeptide Y mRNA in the rat cerebral cortex neuronsNeuropeptides.(1997 Jun)
235.^Clark JT, Gist RS, Kalra SP, Kalra PSAlpha 2-adrenoceptor blockade attenuates feeding behavior induced by neuropeptide Y and epinephrinePhysiol Behav.(1988)
236.^Heilig M, Wahlestedt C, Widerlöv ENeuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptorsEur J Pharmacol.(1988 Nov 22)
237.^Prasad A, Prasad CAgmatine enhances caloric intake and dietary carbohydrate preference in satiated ratsPhysiol Behav.(1996 Oct)
238.^Seo S, Liu P, Leitch BSpatial learning-induced accumulation of agmatine and glutamate at hippocampal CA1 synaptic terminalsNeuroscience.(2011 Sep 29)
239.^Betancourt L, Rada P, Paredes D, Hernández LIn vivo monitoring of cerebral agmatine by microdialysis and capillary electrophoresisJ Chromatogr B Analyt Technol Biomed Life Sci.(2012 Jan 1)
240.^Liu P, Collie ND, Chary S, Jing Y, Zhang HSpatial learning results in elevated agmatine levels in the rat brainHippocampus.(2008)
241.^Leitch B, Shevtsova O, Reusch K, Bergin DH, Liu PSpatial learning-induced increase in agmatine levels at hippocampal CA1 synapsesSynapse.(2011 Feb)
242.^Rushaidhi M, Jing Y, Zhang H, Liu PParticipation of hippocampal agmatine in spatial learning: an in vivo microdialysis studyNeuropharmacology.(2013 Feb)
243.^Wang ZM, Sun GQ, Wang ZA, He RREffects of agmatine on neuronal discharges in rat hippocampal CA1 areaSheng Li Xue Bao.(2003 Dec 25)
244.^Liu P, Jing Y, Collie ND, Chary S, Zhang HMemory-related changes in L-citrulline and agmatine in the rat brainHippocampus.(2009 Jul)
245.^Arteni NS, Lavinsky D, Rodrigues AL, Frison VB, Netto CAAgmatine facilitates memory of an inhibitory avoidance task in adult ratsNeurobiol Learn Mem.(2002 Sep)
246.^Zhou HC, Sun YY, Cai W, He XT, Yi F, Li BM, Zhang XHActivation of β2-adrenoceptor enhances synaptic potentiation and behavioral memory via cAMP-PKA signaling in the medial prefrontal cortex of ratsLearn Mem.(2013 Apr 17)
247.^Dalley JW, Cardinal RN, Robbins TWPrefrontal executive and cognitive functions in rodents: neural and neurochemical substratesNeurosci Biobehav Rev.(2004 Nov)
248.^Gaffan D, Parker AInteraction of perirhinal cortex with the fornix-fimbria: memory for objects and "object-in-place" memoryJ Neurosci.(1996 Sep 15)
249.^Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DDMediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neuronsScience.(1999 Dec 17)
250.^Du K, Montminy MCREB is a regulatory target for the protein kinase Akt/PKBJ Biol Chem.(1998 Dec 4)
251.^Chen X, Li Y, Wang L, Katakowski M, Zhang L, Chen J, Xu Y, Gautam SC, Chopp MIschemic rat brain extracts induce human marrow stromal cell growth factor productionNeuropathology.(2002 Dec)
252.^Lu Y, Christian K, Lu BBDNF: a key regulator for protein synthesis-dependent LTP and long-term memoryNeurobiol Learn Mem.(2008 Mar)
255.^Hawkins RD, Son H, Arancio ONitric oxide as a retrograde messenger during long-term potentiation in hippocampusProg Brain Res.(1998)
256.^Yananli H, Gören MZ, Berkman K, Aricioğlu FEffect of agmatine on brain L-citrulline production during morphine withdrawal in rats: a microdialysis study in nucleus accumbensBrain Res.(2007 Feb 9)
257.^Rastegar K, Roosta H, Zarifkar A, Rafati A, Moosavi MThe Effect of Intra-CA1 Agmatine Microinjection on Water Maze Learning and Memory in RatIran Red Crescent Med J.(2011 May)
258.^Stewart LS, McKay BEAcquisition deficit and time-dependent retrograde amnesia for contextual fear conditioning in agmatine-treated ratsBehav Pharmacol.(2000 Feb)
259.^McKay BE, Lado WE, Martin LJ, Galic MA, Fournier NMLearning and memory in agmatine-treated ratsPharmacol Biochem Behav.(2002 Jun)
260.^Rushaidhi M, Collie ND, Zhang H, Liu PAgmatine selectively improves behavioural function in aged male Sprague-Dawley ratsNeuroscience.(2012 Aug 30)
261.^Liu P, Rushaidhi M, Collie ND, Leong MT, Zhang HBehavioral effects of intracerebroventricular microinfusion of agmatine in adult ratsBehav Neurosci.(2008 Jun)
262.^Liu P, Collie NDBehavioral effects of agmatine in naive rats are task- and delay-dependentNeuroscience.(2009 Sep 29)
263.^Szabó CPhysiological and pathophysiological roles of nitric oxide in the central nervous systemBrain Res Bull.(1996)
264.^Demehri S, Homayoun H, Honar H, Riazi K, Vafaie K, Roushanzamir F, Dehpour ARAgmatine exerts anticonvulsant effect in mice: modulation by alpha 2-adrenoceptors and nitric oxideNeuropharmacology.(2003 Sep)
265.^Bence AK, Worthen DR, Stables JP, Crooks PAAn in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatinePharmacol Biochem Behav.(2003 Feb)
266.^Luszczki JJ, Czernecki R, Wojtal K, Borowicz KK, Czuczwar SJAgmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure modelJ Neural Transm.(2008 Nov)
269.^Garthwaite J, Charles SL, Chess-Williams REndothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brainNature.(1988 Nov 24)
270.^Schoemaker HPolyamines allosterically modulate {3H}nitrendipine binding to the voltage-sensitive calcium channel in rat brainEur J Pharmacol.(1992 Feb 13)
271.^Jeong SY, Ha TS, Park CS, Uhm DY, Chung SNitric oxide directly activates large conductance Ca2+-activated K+ channels (rSlo)Mol Cells.(2001 Aug 31)
272.^Shin JH, Chung S, Park EJ, Uhm DY, Suh CKNitric oxide directly activates calcium-activated potassium channels from rat brain reconstituted into planar lipid bilayerFEBS Lett.(1997 Oct 6)
273.^Denninger JW, Marletta MAGuanylate cyclase and the .NO/cGMP signaling pathwayBiochim Biophys Acta.(1999 May 5)
274.^Bhutada P, Mundhada Y, Humane V, Rahigude A, Deshmukh P, Latad S, Jain KAgmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic ratsProg Neuropsychopharmacol Biol Psychiatry.(2012 Apr 27)
275.^Hwang SL, Liu IM, Tzeng TF, Cheng JTActivation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic ratsDiabetologia.(2005 Apr)
276.^Bergin DH, Liu PAgmatine protects against beta-amyloid25-35-induced memory impairments in the ratNeuroscience.(2010 Aug 25)
277.^Matheus FC, Aguiar AS Jr, Castro AA, Villarinho JG, Ferreira J, Figueiredo CP, Walz R, Santos AR, Tasca CI, Prediger RDNeuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Behav Brain Res.(2012 Dec 1)
278.^Moosavi M, Khales GY, Abbasi L, Zarifkar A, Rastegar KAgmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivationNeuropharmacology.(2012 Apr)
279.^Utkan T, Gocmez SS, Regunathan S, Aricioglu FAgmatine, a metabolite of L-arginine, reverses scopolamine-induced learning and memory impairment in ratsPharmacol Biochem Behav.(2012 Oct)
280.^Zarifkar A, Choopani S, Ghasemi R, Naghdi N, Maghsoudi AH, Maghsoudi N, Rastegar K, Moosavi MAgmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosisEur J Pharmacol.(2010 May 25)
281.^Ahn SK, Hong S, Park YM, Choi JY, Lee WT, Park KA, Lee JEProtective effects of agmatine on lipopolysaccharide-injured microglia and inducible nitric oxide synthase activityLife Sci.(2012 Dec 17)
282.^Kohl S, Heekeren K, Klosterkötter J, Kuhn JPrepulse inhibition in psychiatric disorders--apart from schizophreniaJ Psychiatr Res.(2013 Apr)
283.^Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NRPharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in reviewPsychopharmacology (Berl).(2001 Jul)
284.^Giakoumaki SGCognitive and prepulse inhibition deficits in psychometrically high schizotypal subjects in the general population: relevance to schizophrenia researchJ Int Neuropsychol Soc.(2012 Jul)
285.^Uzbay T, Kayir H, Goktalay G, Yildirim MAgmatine disrupts prepulse inhibition of acoustic startle reflex in ratsJ Psychopharmacol.(2010 Jun)
286.^Pålsson E, Fejgin K, Wass C, Klamer DAgmatine attenuates the disruptive effects of phencyclidine on prepulse inhibitionEur J Pharmacol.(2008 Aug 20)
287.^Kotagale NR, Taksande BG, Wadhwani PJ, Palhade MW, Mendhi SM, Gawande DY, Hadole PN, Chopde CTPsychopharmacological study of agmatine in behavioral tests of schizophrenia in rodentsPharmacol Biochem Behav.(2012 Jan)
288.^Liu P, Smith PF, Appleton I, Darlington CL, Bilkey DKAge-related changes in nitric oxide synthase and arginase in the rat prefrontal cortexNeurobiol Aging.(2004 Apr)
289.^Liu P, Chary S, Devaraj R, Jing Y, Darlington CL, Smith PF, Tucker IG, Zhang HEffects of aging on agmatine levels in memory-associated brain structuresHippocampus.(2008)
290.^Liu P, Gupta N, Jing Y, Zhang HAge-related changes in polyamines in memory-associated brain structures in ratsNeuroscience.(2008 Aug 26)
291.^Gupta N, Jing Y, Collie ND, Zhang H, Liu PAgeing alters behavioural function and brain arginine metabolism in male Sprague-Dawley ratsNeuroscience.(2012 Dec 13)
292.^Liu P, Smith PF, Appleton I, Darlington CL, Bilkey DKPotential involvement of NOS and arginase in age-related behavioural impairmentsExp Gerontol.(2004 Aug)
293.^Liu P, Smith PF, Appleton I, Darlington CL, Bilkey DKHippocampal nitric oxide synthase and arginase and age-associated behavioral deficitsHippocampus.(2005)
294.^Rushaidhi M, Zhang H, Liu PEffects of prolonged agmatine treatment in aged male Sprague-Dawley ratsNeuroscience.(2013 Mar 27)
295.^Joshi MS, Ferguson TB Jr, Johnson FK, Johnson RA, Parthasarathy S, Lancaster JR JrReceptor-mediated activation of nitric oxide synthesis by arginine in endothelial cellsProc Natl Acad Sci U S A.(2007 Jun 12)
296.^Haulică I, Bild W, Iliescu R, Georgescu R, Frunză FPreliminary research on possible relationship of NO with agmatine at the vascular levelRom J Physiol.(1999 Jan-Jun)
297.^Schwartz D, Peterson OW, Mendonca M, Satriano J, Lortie M, Blantz RCAgmatine affects glomerular filtration via a nitric oxide synthase-dependent mechanismAm J Physiol.(1997 May)
299.^Nitric Oxide-induced Mobilization of Intracellular Calcium via the Cyclic ADP-ribose Signaling Pathway.()
300.^Stoyanovsky D, Murphy T, Anno PR, Kim YM, Salama GNitric oxide activates skeletal and cardiac ryanodine receptorsCell Calcium.(1997 Jan)
301.^Galione A, Lee HC, Busa WBCa(2+)-induced Ca2+ release in sea urchin egg homogenates: modulation by cyclic ADP-riboseScience.(1991 Sep 6)
302.^Lee HC, Galione A, Walseth TFCyclic ADP-ribose: metabolism and calcium mobilizing functionVitam Horm.(1994)
303.^Satriano J, Cunard R, Peterson OW, Dousa T, Gabbai FB, Blantz RCEffects on kidney filtration rate by agmatine requires activation of ryanodine channels for nitric oxide generationAm J Physiol Renal Physiol.(2008 Apr)
304.^Jagnandan D, Sessa WC, Fulton DIntracellular location regulates calcium-calmodulin-dependent activation of organelle-restricted eNOSAm J Physiol Cell Physiol.(2005 Oct)
305.^Liou SF, Wu JR, Lai WT, Sheu SH, Chen IJ, Yeh JLThe vasorelaxing action of labedipinedilol-A involves endothelial cell-derived NO and eNOS expression caused by calcium influxJ Cardiovasc Pharmacol.(2005 Mar)
307.^Kakizawa S, Yamazawa T, Iino MNitric oxide-induced calcium release: activation of type 1 ryanodine receptor by endogenous nitric oxideChannels (Austin).(2013 Jan 1)
308.^Chen CT, Chen W, Chung HH, Cheng KC, Yeh CH, Cheng JTActivation of imidazoline I-2B receptor by metformin to increase glucose uptake in skeletal muscleHorm Metab Res.(2011 Sep)
309.^Yamboliev IA, Mutafova-Yambolieva VNPI3K and PKC contribute to membrane depolarization mediated by alpha2-adrenoceptors in the canine isolated mesenteric veinBMC Physiol.(2005 Jun 15)
310.^Lu XL, Xu ZL, Yao XL, Su FJ, Ye CH, Li J, Lin YC, Wang GL, Zeng JS, Huang RX, Ou JS, Sun HS, Wang LP, Pang JY, Pei ZMarine cyclotripeptide X-13 promotes angiogenesis in zebrafish and human endothelial cells via PI3K/Akt/eNOS signaling pathwaysMar Drugs.(2012 Jun)
311.^Shi F, Wang YC, Zhao TZ, Zhang S, Du TY, Yang CB, Li YH, Sun XQEffects of simulated microgravity on human umbilical vein endothelial cell angiogenesis and role of the PI3K-Akt-eNOS signal pathwayPLoS One.(2012)
312.^Jung HJ, Jeon YH, Bokara KK, Koo BN, Lee WT, Park KA, Lee JEAgmatine promotes the migration of murine brain endothelial cells via multiple signaling pathwaysLife Sci.(2013 Jan 17)
313.^Auguet M, Viossat I, Marin JG, Chabrier PESelective inhibition of inducible nitric oxide synthase by agmatineJpn J Pharmacol.(1995 Nov)
314.^Jianmongkol S, Vuletich JL, Bender AT, Demady DR, Osawa YAminoguanidine-mediated inactivation and alteration of neuronal nitric-oxide synthaseJ Biol Chem.(2000 May 5)
315.^Wolff DJ, Lubeskie AAminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthaseArch Biochem Biophys.(1995 Jan 10)
316.^Nakatsuka M, Nakatsuka K, Osawa YMetabolism-based inactivation of penile nitric oxide synthase activity by guanabenzDrug Metab Dispos.(1998 May)
317.^Li Q, Shang ZL, Yin JX, Wang YH, He RREffect of agmatine on intracellular free calcium concentration in isolated rat ventricular myocytesSheng Li Xue Bao.(2002 Dec 25)
318.^Li Q, Yin JX, He RREffect of agmatine on L-type calcium current in rat ventricular myocytesActa Pharmacol Sin.(2002 Mar)
319.^Lortie MJ, Novotny WF, Peterson OW, Vallon V, Malvey K, Mendonca M, Satriano J, Insel P, Thomson SC, Blantz RCAgmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the ratJ Clin Invest.(1996 Jan 15)
320.^Gao Y, Gumusel B, Koves G, Prasad A, Hao Q, Hyman A, Lippton HAgmatine: a novel endogenous vasodilator substanceLife Sci.(1995)
321.^Ishikawa T, Misonou T, Ikeno M, Sato K, Sakamaki TN omega-hydroxyagmatine: a novel substance causing endothelium-dependent vasorelaxationBiochem Biophys Res Commun.(1995 Sep 5)
322.^Gill F, Pelit T, Terzioğlu B, Ekinci O, Gören MZEffects of agmatine on the survival rate in rats bled to hemorrhageArzneimittelforschung.(2011)
323.^Ernsberger P, Giuliano R, Willette RN, Granata AR, Reis DJHypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medullaJ Hypertens Suppl.(1988 Dec)
324.^Ernsberger P, Giuliano R, Willette RN, Reis DJRole of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medullaJ Pharmacol Exp Ther.(1990 Apr)
325.^Jou SB, Liu IM, Cheng JTActivation of imidazoline receptor by agmatine to lower plasma glucose in streptozotocin-induced diabetic ratsNeurosci Lett.(2004 Mar 25)
326.^Schäfer U, Raasch W, Qadri F, Chun J, Dominiak PEffects of agmatine on the cardiovascular system of spontaneously hypertensive ratsAnn N Y Acad Sci.(1999 Jun 21)
327.^Sun MK, Regunathan S, Reis DJCardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized ratClin Exp Hypertens.(1995 Jan-Feb)
328.^Khan S, Evans AA, Hughes S, Smith MEBeta-endorphin decreases fatigue and increases glucose uptake independently in normal and dystrophic miceMuscle Nerve.(2005 Apr)
329.^Cheng JT, Liu IM, Tzeng TF, Tsai CC, Lai TYPlasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic ratsHorm Metab Res.(2002 Oct)
330.^Evans AA, Khan S, Smith MEEvidence for a hormonal action of beta-endorphin to increase glucose uptake in resting and contracting skeletal muscleJ Endocrinol.(1997 Nov)
331.^Radosevich PM, Williams PE, McRae JR, Lacy WW, Orth DN, Abumrad NNBeta-endorphin inhibits glucose production in the conscious dogJ Clin Invest.(1984 Apr)
332.^Curry DL, Bennett LL, Li CHStimulation of insulin secretion by beta-endorphins (1-27 & 1-31)Life Sci.(1987 May 25)
333.^Hauner H, Glatting G, Ditschuneit HH, Pfeiffer EFEndogenous opiates do not influence glucose and lipid metabolism in rat adipocytesExp Clin Endocrinol.(1988 Aug)
334.^Kalra SP, Pearson E, Sahu A, Kalra PSAgmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitroNeurosci Lett.(1995 Jul 21)
335.^Hong S, Lee JE, Kim CY, Seong GJAgmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell lineBMC Neurosci.(2007 Oct 2)
336.^Hong S, Kim CY, Lee WS, Shim J, Yeom HY, Seong GJOcular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat modelExp Eye Res.(2010 Jan)
337.^Hong S, Hara H, Shimazawa M, Hyakkoku K, Kim CY, Seong GJRetinal protective effects of topically administered agmatine on ischemic ocular injury caused by transient occlusion of the ophthalmic arteryBraz J Med Biol Res.(2012 Mar)
338.^Al Masri AA, El Eter EAgmatine induces gastric protection against ischemic injury by reducing vascular permeability in ratsWorld J Gastroenterol.(2012 May 14)
339.^Utkan T, Ulak G, Yildiran HG, Yardimoglu M, Gacar MNInvestigation on the mechanism involved in the effects of agmatine on ethanol-induced gastric mucosal injury in ratsLife Sci.(2000 Mar 24)
340.^Glavin GB, Smyth DDEffects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in ratsBr J Pharmacol.(1995 Feb)
341.^Glavin GB, Carlisle MA, Smyth DDAgmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in ratsJ Pharmacol Exp Ther.(1995 Aug)
342.^Zádori ZS, Fehér A, Al-Khrasani M, Lackó E, Tóth VE, Brancati SB, Hein L, Mátyus P, Gyires KImidazoline versus alpha2-adrenoceptors in the control of gastric motility in miceEur J Pharmacol.(2013 Apr 5)
343.^Molderings GJ, Burian M, Homann J, Nilius M, Göthert MPotential relevance of agmatine as a virulence factor of Helicobacter pyloriDig Dis Sci.(1999 Dec)
344.^Bidet M, Tauc M, Koechlin N, Poujeol PVideo microscopy of intracellular pH in primary cultures of rabbit proximal and early distal tubulesPflugers Arch.(1990 May)
345.^Jurkiewicz NH, Garcez do Carmo L, Hirata H, da Costa Santos W, Jurkiewicz AFunctional properties of agmatine in rat vas deferensEur J Pharmacol.(1996 Jul 4)
346.^Santos WC, Smaili SS, Jurkiewicz A, Piçarro I, Garcez-do-Carmo LDual effect of agmatine in the bisected rat vas deferensJ Pharm Pharmacol.(2003 Mar)
347.^Presta A, Liu J, Sessa WC, Stuehr DJSubstrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activityNitric Oxide.(1997 Feb)
348.^Aglawe MM, Taksande BG, Kuldhariya SS, Chopde CT, Umekar MJ, Kotagale NRParticipation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in ratsFundam Clin Pharmacol.(2013 Apr 11)
349.^Ozden O, Kayir H, Ozturk Y, Uzbay TAgmatine blocks ethanol-induced locomotor hyperactivity in male miceEur J Pharmacol.(2011 Apr 4)
350.^Sameer SM, Chakraborty SS, Ugale RRAgmatine attenuates acquisition but not the expression of ethanol conditioned place preference in mice: a role for imidazoline receptorsBehav Pharmacol.(2013 Apr)
351.^Uzbay T, Kose A, Kayir H, Ulusoy G, Celik TSex-related effects of agmatine on caffeine-induced locomotor activity in Swiss Webster miceEur J Pharmacol.(2010 Mar 25)
Primary Use